NASDAQ:VERU Veru (VERU) Stock Price, News & Analysis $0.37 0.00 (-0.11%) Closing price 04:00 PM EasternExtended Trading$0.38 +0.01 (+2.50%) As of 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Veru Stock (NASDAQ:VERU) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Veru alerts:Sign Up Key Stats Today's Range$0.37▼$0.4050-Day Range$0.37▼$0.7052-Week Range$0.36▼$1.42Volume2.27 million shsAverage Volume1.48 million shsMarket Capitalization$54.63 millionP/E RatioN/ADividend YieldN/APrice Target$4.00Consensus RatingBuy Company Overview Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company's development program includes enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, a selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection on oxygen support who are at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida. Read More Veru Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks34th Percentile Overall ScoreVERU MarketRank™: Veru scored higher than 34% of companies evaluated by MarketBeat, and ranked 747th out of 923 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingVeru has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageVeru has received no research coverage in the past 90 days.Read more about Veru's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Veru are expected to decrease in the coming year, from ($0.22) to ($0.28) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Veru is -1.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Veru is -1.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioVeru has a P/B Ratio of 1.69. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Veru's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.65% of the outstanding shares of Veru have been sold short.Short Interest Ratio / Days to CoverVeru has a short interest ratio ("days to cover") of 4.6.Change versus previous monthShort interest in Veru has recently increased by 3,789.66%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldVeru does not currently pay a dividend.Dividend GrowthVeru does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted7.65% of the outstanding shares of Veru have been sold short.Short Interest Ratio / Days to CoverVeru has a short interest ratio ("days to cover") of 4.6.Change versus previous monthShort interest in Veru has recently increased by 3,789.66%, indicating that investor sentiment is decreasing significantly. News and Social Media2.3 / 5News Sentiment0.22 News SentimentVeru has a news sentiment score of 0.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.38 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 9 news articles for Veru this week, compared to 2 articles on an average week.Search Interest15 people have searched for VERU on MarketBeat in the last 30 days. This is an increase of 150% compared to the previous 30 days.MarketBeat FollowsOnly 4 people have added Veru to their MarketBeat watchlist in the last 30 days. This is a decrease of -20% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Veru insiders have not sold or bought any company stock.Percentage Held by Insiders15.20% of the stock of Veru is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions47.16% of the stock of Veru is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Veru's insider trading history. Receive VERU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Veru and its competitors with MarketBeat's FREE daily newsletter. Email Address VERU Stock News HeadlinesVeru (VERU) Expected to Announce Earnings on TuesdayAugust 7 at 3:57 AM | americanbankingnews.comVeru (NASDAQ:VERU) Shares Set to Reverse Split on Monday, August 11thAugust 7 at 2:29 AM | americanbankingnews.comMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.August 8 at 2:00 AM | Brownstone Research (Ad)Veru Announces Reverse Stock SplitAugust 6 at 8:30 AM | globenewswire.comVeru to Report Fiscal 2025 Third Quarter Financial Results on August 12thAugust 5 at 11:56 PM | finance.yahoo.comShort Interest in Veru Inc. (NASDAQ:VERU) Grows By 3,789.7%August 3, 2025 | americanbankingnews.comVeru Stock Short Interest Report | NASDAQ:VERU | BenzingaJuly 31, 2025 | benzinga.comVeru to Participate in the 2025 BTIG Virtual Biotech ConferenceJuly 22, 2025 | globenewswire.comSee More Headlines VERU Stock Analysis - Frequently Asked Questions How have VERU shares performed this year? Veru's stock was trading at $0.6505 on January 1st, 2025. Since then, VERU shares have decreased by 42.7% and is now trading at $0.3727. How were Veru's earnings last quarter? Veru Inc. (NASDAQ:VERU) issued its quarterly earnings data on Thursday, May, 8th. The company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.06) by $0.01. Read the conference call transcript. When did Veru's stock split? Shares of Veru reverse split on Monday, August 11th 2025.The 1-10 reverse split was announced on Wednesday, August 6th 2025. The number of shares owned by shareholders will be adjusted after the closing bell on Friday, August 8th 2025. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. Who are Veru's major shareholders? Top institutional shareholders of Veru include Geode Capital Management LLC (1.10%), Envestnet Asset Management Inc. (0.42%), 180 Wealth Advisors LLC (0.31%) and Blair William & Co. IL (0.26%). Insiders that own company stock include Mitchell Shuster Steiner, Harry Fisch, Michael L Rankowitz, K Gary Barnette and Mario Eisenberger. View institutional ownership trends. How do I buy shares of Veru? Shares of VERU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Veru own? Based on aggregate information from My MarketBeat watchlists, some other companies that Veru investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Ford Motor (F), Walt Disney (DIS) and Moderna (MRNA). Company Calendar Last Earnings5/08/2025Today8/08/2025Next Earnings (Estimated)8/12/2025Fiscal Year End9/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED PRODUCTS Sub-IndustryPersonal Products Current SymbolNASDAQ:VERU CIK863894 Webwww.veruhealthcare.com Phone(305) 509-6897Fax312-595-9122Employees230Year FoundedN/APrice Target and Rating Average Price Target for Veru$4.00 High Price Target$5.00 Low Price Target$3.00 Potential Upside/Downside+973.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($0.24) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$37.80 million Net MarginsN/A Pretax Margin-286.19% Return on Equity-128.51% Return on Assets-76.51% Debt Debt-to-Equity RatioN/A Current Ratio3.80 Quick Ratio3.80 Sales & Book Value Annual Sales$16.89 million Price / Sales3.23 Cash FlowN/A Price / Cash FlowN/A Book Value$0.22 per share Price / Book1.69Miscellaneous Outstanding Shares146,580,000Free Float124,303,000Market Cap$54.63 million OptionableOptionable Beta-0.72 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NASDAQ:VERU) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredChina's 500 Million Year AdvantageThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veru Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veru With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.